This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Novartis Ag. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Joseph Michael Kahn: Innovator in Multiple Sclerosis Treatment
Introduction
Joseph Michael Kahn is a notable inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis. With a total of 4 patents, Kahn's work has the potential to impact many lives.
Latest Patents
Kahn's latest patents focus on innovative regimens and methods for treating multiple sclerosis using ofatumumab. The first patent discloses treatment regimens that utilize the administration of ofatumumab, an anti-CD20 monoclonal antibody, to patients during both a loading dose regimen and a maintenance regimen. This approach aims to enhance the effectiveness of treatment for individuals suffering from multiple sclerosis.
Career Highlights
Joseph Michael Kahn is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field, further advancing research and treatment options for multiple sclerosis.
Collaborations
Kahn has worked alongside notable colleagues such as Marina Savelieva Praz and Algirdas Jonas Kakarieka Weisskopf. Their combined expertise contributes to the innovative solutions being developed in the realm of multiple sclerosis treatment.
Conclusion
Joseph Michael Kahn's contributions to the field of medicine, particularly in the treatment of multiple sclerosis, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to improving patient outcomes through innovative therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
